Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

DALARGIN™ lyophilisate for IV/IM injection 1mg, 10pcs

🔥 7 items sold in last 3 hours
20 people are viewing this product
Brand:

$88.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

DALARGIN™ solution for IV/IM injection 1mg/ml (1ml), 10pcs

$88.0
Add to cart

Analogs of DALARGIN™

DALARGIN-ELLARA™ lyophilisate for IV/IM injection 1mg, 10pcs

$89.5
Add to cart

Table of Contents

DALARGIN™ 1mg Lyophilisate 10pcs Buy Online

DALARGIN: A Comprehensive Overview

DALARGIN, a potent medication, offers a unique approach to managing various conditions. Its mechanism of action, detailed below, highlights its effectiveness in specific therapeutic areas. Understanding its properties and potential side effects is crucial for informed healthcare decisions.

This overview provides essential information regarding DALARGIN’s therapeutic applications, administration, potential benefits, and drawbacks. This information is intended for educational purposes and should not replace professional medical advice.

Always consult with a healthcare professional before starting any new medication, including DALARGIN, to ensure it’s safe and appropriate for your individual needs and health status. Proper medical guidance is paramount for optimal treatment outcomes and minimizing potential risks.

What is DALARGIN?

DALARGIN is a peptide medication administered via intravenous (IV) or intramuscular (IM) injection. It’s presented as a lyophilisate, meaning it’s a freeze-dried powder that needs to be reconstituted with a sterile solution before use. Each vial typically contains a single dose, often 1mg, although formulations may vary.

This medication is not a readily available over-the-counter drug. Its usage is primarily confined to hospital settings or under strict medical supervision due to its administration method and potential side effects. The precise formulation and preparation instructions should always be followed carefully as per the provided package insert.

DALARGIN’s unique chemical structure gives it specific pharmacological properties. Its primary action involves modulating various physiological processes, impacting the body’s response to inflammation and tissue damage. Further details about its mechanism of action are discussed in a subsequent section.

Importantly, DALARGIN is not a cure-all but a therapeutic agent used as part of a comprehensive treatment plan. Its effectiveness is dependent on various factors, including the underlying condition, the patient’s overall health, and adherence to the prescribed dosage and administration schedule. Improper use may lead to adverse effects.

Understanding the precise role of DALARGIN within a treatment regimen is crucial. It is not a standalone treatment for most conditions, but rather a complementary medication that works in conjunction with other therapies to achieve better outcomes. Always follow your physician’s instructions.

Therapeutic Uses of DALARGIN

DALARGIN’s therapeutic applications are primarily focused on conditions involving inflammation and tissue damage. While not a first-line treatment for all these conditions, it often plays a supportive role within a broader treatment strategy aimed at reducing inflammation and promoting healing.

One significant area is the management of acute pancreatitis and pancreatic necrosis. In these severe conditions, DALARGIN can help to mitigate the inflammatory response and potentially reduce the severity of complications. It’s crucial to remember that this is typically part of a comprehensive care plan involving other crucial interventions.

Another area where DALARGIN may be used is in the treatment of peptic ulcers. Its anti-ulcer properties, likely related to its effect on gastric secretions, can support the healing process. However, the use of DALARGIN in this context should be guided by a physician’s assessment and integrated with other standard ulcer treatments.

Furthermore, DALARGIN has shown promise in addressing certain vascular disorders. Research suggests potential benefits in managing conditions such as Buerger’s disease and atherosclerosis, although more extensive studies are needed to fully elucidate its efficacy and mechanisms in these areas. The use in these conditions remains largely investigational.

Finally, some studies have explored the use of DALARGIN in managing certain neurological or psychomotor disturbances, particularly those associated with alcohol abuse. However, the evidence base for this application remains limited and requires further investigation to confirm its effectiveness and safety.

Mechanism of Action

DALARGIN’s precise mechanism of action is complex and not fully elucidated, but it’s understood to involve interactions with multiple physiological pathways. Its effects are primarily attributed to its influence on various peptide systems within the body, impacting processes related to inflammation and tissue repair.

One key aspect is its ability to modulate the activity of opioid receptors. While not a direct opioid agonist, DALARGIN interacts with these receptors, influencing pain perception and potentially contributing to its analgesic effects in certain situations. This interaction is believed to contribute to the reduction of pain associated with some of the conditions it treats.

Furthermore, DALARGIN exhibits anti-inflammatory properties. This effect likely involves interactions with various inflammatory mediators, reducing the production or activity of substances that contribute to inflammation and tissue damage. This anti-inflammatory action is thought to play a critical role in its therapeutic benefits in conditions such as pancreatitis.

Additionally, DALARGIN may influence gastric secretions, contributing to its potential use in managing peptic ulcers. This effect is believed to help reduce the irritation and promote the healing of the ulcerated tissues. The exact mechanisms underlying this effect are still under investigation.

It’s important to note that the precise interactions and downstream effects of DALARGIN are still under investigation. Ongoing research continues to unravel the complexities of its multifaceted actions and further elucidate its therapeutic potential across a range of clinical applications. The full understanding of its effects is still an active area of research.

Dosage and Administration

DALARGIN is administered parenterally, meaning it’s injected either intravenously (IV) or intramuscularly (IM). It’s crucial to understand that this medication is not for self-administration; it must be given by a trained healthcare professional in a controlled medical setting.

The specific dosage of DALARGIN will vary depending on the indication, the patient’s condition, and other factors. A physician will determine the appropriate dose and frequency based on a thorough assessment of the individual’s needs. Always follow the prescribed dosage regimen precisely.

Before administration, the lyophilized powder must be reconstituted with a suitable sterile diluent, typically normal saline (0.9% sodium chloride solution). The manufacturer’s instructions should be followed meticulously to ensure proper reconstitution and prevent contamination.

For intravenous administration, the reconstituted solution is typically injected slowly over several minutes to minimize the risk of adverse reactions. Intramuscular injection, on the other hand, involves injecting the solution into a large muscle mass, often the buttock or thigh. The injection site should be rotated to avoid irritation.

The duration of treatment with DALARGIN will also vary depending on the clinical situation. The physician will monitor the patient’s response and adjust the treatment plan accordingly. Treatment duration may range from several days to several weeks. Regular monitoring is essential to ensure efficacy and safety.

Pros of Using DALARGIN

DALARGIN offers several potential advantages when used appropriately as part of a comprehensive treatment plan. These benefits stem from its multifaceted mechanism of action, impacting several physiological processes relevant to the conditions it’s used to treat.

One key advantage is its potential to reduce inflammation. This anti-inflammatory effect can be particularly beneficial in conditions characterized by excessive inflammation, such as acute pancreatitis or certain vascular disorders. By mitigating inflammation, DALARGIN may help to lessen the severity of symptoms and promote healing.

Furthermore, DALARGIN may contribute to pain management in certain contexts. Its interaction with opioid receptors and its anti-inflammatory action may lead to a reduction in pain perception, improving the patient’s overall comfort and well-being. This analgesic effect can be a significant benefit in conditions associated with considerable pain.

In addition, DALARGIN may support tissue repair. By reducing inflammation and potentially promoting certain cellular processes, DALARGIN may facilitate the healing process in damaged tissues. This effect can be particularly relevant in conditions such as peptic ulcers where tissue regeneration is crucial for recovery.

Finally, DALARGIN’s relatively short half-life allows for titration of dosage and careful monitoring of its effects. This makes it possible to adjust treatment to meet the specific needs of the patient and minimize potential side effects. This flexibility can be a valuable asset in managing diverse clinical situations.

Cons of Using DALARGIN

While DALARGIN offers potential therapeutic benefits, it’s crucial to acknowledge potential drawbacks. As with any medication, the decision to use DALARGIN should be made in consultation with a healthcare professional, weighing the potential benefits against the risks.

One significant consideration is the potential for adverse reactions. While the exact incidence and severity of side effects vary, some patients may experience reactions at the injection site, such as pain, redness, or swelling. More systemic effects, although less common, are also possible.

Another aspect to consider is that DALARGIN’s effectiveness is not universally established across all conditions. While research suggests potential benefits in certain areas, the evidence base for its efficacy in some applications remains limited. Further studies are needed to solidify its role in certain therapeutic areas.

Furthermore, DALARGIN’s route of administration presents practical limitations. Intravenous or intramuscular injection requires medical expertise and is not suitable for self-administration. This necessitates access to healthcare professionals for administration, which might pose challenges depending on the circumstances.

Finally, the relatively limited availability of DALARGIN compared to other medications could pose a constraint. Its use is largely confined to specific clinical settings and may not be readily accessible in all healthcare facilities. Access to this medication may be dependent on location and healthcare resources.

Contraindications and Precautions

Before administering DALARGIN, healthcare professionals must carefully consider potential contraindications and take necessary precautions. This is crucial to ensure patient safety and optimize treatment outcomes. A thorough medical history and assessment are essential before initiating therapy.

While specific contraindications for DALARGIN may vary depending on the patient’s individual health profile and the specific clinical context, known hypersensitivity or allergic reactions to the drug or its components represent a clear contraindication. Any history of such reactions should be carefully documented and considered before initiating treatment.

Furthermore, caution is warranted in patients with pre-existing kidney or liver impairment. The medication’s metabolism and excretion pathways might be affected in such cases, potentially leading to an increased risk of adverse effects. Careful monitoring and potentially adjusted dosage may be necessary.

Patients with a history of cardiovascular disease should also be closely monitored during DALARGIN therapy. The medication’s effects on the cardiovascular system, while generally considered mild, warrant careful observation in individuals with pre-existing conditions. Regular monitoring of vital signs is essential.

Finally, pregnant or breastfeeding women should only receive DALARGIN after a thorough risk-benefit assessment by their physician. The potential effects of DALARGIN on fetal development or the nursing infant are not fully established, necessitating caution in these specific populations. Alternative treatments should be considered when possible.

Side Effects

While generally well-tolerated, DALARGIN can produce side effects, although their frequency and severity vary among individuals. It’s important to be aware of these potential adverse reactions to ensure prompt recognition and appropriate management if they occur. The occurrence of side effects doesn’t necessarily indicate a problem, but it warrants attention.

Local reactions at the injection site are among the most commonly reported side effects. These can include pain, redness, swelling, or inflammation at the injection site. These reactions are usually mild and transient, resolving spontaneously within a short time. However, persistent or worsening symptoms should be reported to a healthcare provider.

Systemic side effects, while less frequent, are also possible. These can include allergic reactions, ranging from mild to severe. Symptoms of allergic reactions can vary and might manifest as skin rashes, itching, hives, swelling of the face, lips, or tongue (angioedema), or difficulty breathing. Immediate medical attention is crucial in case of severe allergic reactions.

Other less common side effects might include gastrointestinal disturbances, such as nausea, vomiting, or diarrhea. These symptoms are usually mild and self-limiting, but persistent or severe gastrointestinal distress should be reported. Changes in appetite or bowel habits should also be noted.

It’s crucial to remember that this information is not exhaustive, and individual experiences can vary. Any unusual or concerning symptoms experienced during or after DALARGIN administration should be promptly reported to the prescribing physician. Open communication with your healthcare provider is crucial for safe and effective medication management.

Conclusion

DALARGIN, administered via intravenous or intramuscular injection, presents a unique therapeutic approach with potential benefits in managing specific inflammatory and ulcerative conditions. Its mechanism of action, while complex and still under investigation, points to its ability to modulate inflammatory responses and potentially influence pain perception.

While offering potential advantages in reducing inflammation and supporting tissue repair, DALARGIN also carries potential risks, including local and systemic side effects. The decision to use DALARGIN should always be made in consultation with a healthcare professional who can weigh the potential benefits against the risks based on the individual patient’s health profile and specific clinical context.

The information provided here is intended for educational purposes and should not be considered medical advice. Always consult with a qualified healthcare provider before starting any new medication, including DALARGIN. They can provide personalized guidance on its appropriate use, potential benefits, and potential risks based on your individual needs and medical history.

Further research is needed to fully elucidate DALARGIN’s mechanism of action and to further define its role in the management of various conditions. Ongoing studies may help to refine its clinical applications and optimize its therapeutic potential. The information presented here reflects the current understanding of this complex medication.

Remember, responsible medication use requires a partnership between the patient and their healthcare provider. Open communication about potential benefits, risks, and any observed side effects is crucial for safe and effective treatment. Your health and well-being should always be the priority.

  • Dalargin™ Lyophilisate For Iv/Im Injection 1Mg, 10Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Dalargin™ Lyophilisate For Iv/Im Injection 1Mg, 10Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Dalargin™ Lyophilisate For Iv/Im Injection 1Mg, 10Pcs Buy Online 6
    [Medical reviewer]

    Dr. David J. Bronster, MD, is a distinguished Professor of Neurology and Neurological Consultant to the Recanati/Miller Transplantation Institute. With an impressive 36-year career in consultative wor...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “DALARGIN™ lyophilisate for IV/IM injection 1mg, 10pcs”

Your email address will not be published. Required fields are marked

Similar products

GAVISCON™ oral suspension mint 150ml, 1pc

$37.5
Add to cart

GAVISCON™ mint chewable tablets, 48pcs

$55.0
Add to cart

GASTROFARM™ tablets, 6pcs

$15.0
Add to cart

GAVISCON™ DOUBLE ACTION oral suspension 10ml, 12 sachets

$41.5
Add to cart

GAVISCON™ DOUBLE ACTION oral suspension mint 150ml, vial 1pc

$45.5
Add to cart

GAVISCON™ DOUBLE ACTION oral suspension mint 300ml, vial 1pc

$55.0
Add to cart

GASTAL™ lozenges, 12pcs

$29.5
Add to cart

GASTAL™ lozenges, 12pcs

$28.0
Add to cart

GASTAL™ lozenges, 30pcs

$45.5
Add to cart

GASTROSTAT™ tablets 100mg, 30pcs

$67.0
Add to cart

GASTROSTAT™ tablets 100mg, 90pcs

$146.5
Add to cart

GASTROFARM™ tablets, 18pcs

$29.5
Add to cart

VITRIDINOL™ tablets 120mg, 112pcs

$71.0
Add to cart

VITRIDINOL™ tablets 120mg, 56pcs

$39.0
Add to cart

BISMUTH TRIPOTASSIUM DICITRATE-VERTEX™ tablets 120mg, 28pcs

$20.0
Add to cart

BEFUNGIN™ oral solution 100ml, vial 1pc

$40.0
Add to cart

BELLASTEZIN™ tablets, 10pcs

$15.0
Add to cart

BELLASTEZIN™ tablets 300mg+15mg, 10pcs

$12.0
Add to cart

ANTAREYT™ VALENTA chewable tablets 800mg+40mg, 12pcs

$28.0
Add to cart

ALMAGEL™ NEO oral suspension 10ml, 10pcs

$39.0
Add to cart

ALMAGEL™ NEO oral suspension 170ml, 1pc

$47.0
Add to cart

ALMAGEL™ oral suspension 10ml, 10pcs

$35.0
Add to cart

ALMAGEL™ oral suspension 170ml, 1pc

$39.0
Add to cart

ALMAGEL™ A oral suspension 170ml, 1pc

$43.0
Add to cart
Select your currency